MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejcb.2026.151565

Медицинская библиотека · European journal of cell biology · 2026

TCF3 safeguards tumor-intrinsic interferon competence to restrain prostate cancer progression and immune escape.

Zhai Shengjie, Li Hong, Liu Yuhan, Zhang Qin, Li Jing, Wang Zixian, Jiang Linxi, Zhang Peng, Lu Ying, Wei Gong-Hong

СтатьяПеревод в очереди

Аннотация

Prostate cancer commonly remains refractory to checkpoint blockade, consistent with an immune-cold microenvironment and tumor-intrinsic defects in interferon signaling. We report that loss of the basic helix-loop-helix transcription factor TCF3 defines a tumor-intrinsic mechanism that simultaneously drives aggressive progression and immune evasion. TCF3 expression is reduced in advanced and metastatic prostate cancer across multiple cohorts and in a Pten-driven model. In androgen-independent prostate cancer cells and organoids, TCF3 depletion enhances proliferation, clonogenicity, migration, and EMT-associated programs, while overexpression of TCF3 isoforms suppresses these malignant phenotypes. Transcriptomic profiling further shows that TCF3 loss profoundly downregulates interferon-α/γ response programs. Mechanistically, TCF3 promotes transcription of STAT2, preserving basal and inducible interferon signaling and downstream ISG expression; TCF3-deficient tumors exhibit reduced immune infiltration and impaired CD8+ T cell effector function in vivo. Notably, therapeutic innate immune activation partially restores interferon responses, and poly(I:C) plus PD-1 blockade reinvigorates cytotoxic T cell activity and markedly suppresses tumor growth. These data support TCF3 as a biomarker of interferon competence and a rational basis for selecting patients for innate agonist-checkpoint combinations.

Для цитирования: Zhai Shengjie, Li Hong, Liu Yuhan, Zhang Qin, Li Jing, Wang Zixian, Jiang Linxi, Zhang Peng, Lu Ying, Wei Gong-Hong. TCF3 safeguards tumor-intrinsic interferon competence to restrain prostate cancer progression and immune escape.. European journal of cell biology. 2026. DOI: 10.1016/j.ejcb.2026.151565.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.